Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases

Clinical hyperthermic intraperitoneal chemotherapy (HIPEC) is regarded as a potential treatment that can prolong survival of patients with peritoneal metastases after cytoreductive surgery. However, treated tumor cells are prone to becoming heat resistant to HIPEC therapy through high expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Liu, Peng, Wen, Yingfei, Li, Kuan, Bi, Bo, Li, Bin-bin, Qiu, Miaojuan, Zhang, Shiqiang, Li, You, Li, Jia, Chen, Hengxing, Yin, Yuan, Zeng, Leli, Zhang, Changhua, He, Yulong, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265871/
https://www.ncbi.nlm.nih.gov/pubmed/37316830
http://dx.doi.org/10.1186/s12943-023-01790-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265871/
https://www.ncbi.nlm.nih.gov/pubmed/37316830
http://dx.doi.org/10.1186/s12943-023-01790-2

Ejemplares similares